Below we list the current VCT offers available for investment. Each is accompanied by a brief commentary. For each of our Featured Offers we also provide an extended research note.
VCTs are riskier than conventional investments so they're not for everyone. Before you invest you should ensure you have read and understood the product's Application Pack and the Risks and Commitments.
NEW OFFER: this is a £30 million fund raise for the Octopus AIM VCT and Octopus AIM VCT 2 (together the Octopus AIM VCTs). Investors will have exposure to a well-established portfolio of maturing and profitable AIM companies plus earlier-stage businesses from newer investments.
New, evergreen share class – growth-focused but with a preference for asset-backed businesses, a particular specialism of Downing, which may offer some downside protection. Unusual zero-discount buyback policy. For investors who don’t mind foregoing dividend income for the first few years, this may be an offer to consider.
This new share class for the longstanding Downing Four VCT is looking to raise £10 million (with a further over-allotment of £10m) to invest in early-stage healthcare, biotechnology and life sciences businesses. Downing is the overall manager, but will use the skills of specialist healthcare investor BioScience Managers to source and manage deals.
Generalist VCT with a focus on growth businesses, particularly in software and computer services. Now co-invests alongside Draper Esprit which should enhance deal flow and opportunities to invest in larger more established businesses.
Foresight 4 VCT plc has a long history of takeovers, mergers and diverse investment mandates. Look beyond this, however, and the underlying story is a good one, with potentially promising prospects. The Foresight 4 VCT is merging with its smaller sibling, Foresight 3 VCT, and will together raise £50 million, with an over-allotment facility of a further £50 million.
Pembroke's manager, Oakley Capital, is a long established name in venture capital investing. This VCT is one of the few investing in growth-orientated companies: as such the recent rule changes on MBOs have little or no impact on them. Investments are focused on scalable consumer brands; ones which investors can walk down the high street and see. This VCT is worthy of consideration.
Foresight 4 VCT plc has a long history of takeovers, mergers and diverse investment mandates. Look beyond this, however, and the underlying story is a good one, with potentially promising prospects. The Foresight 4 VCT is ...
NEW OFFER: this is a £30 million fund raise for the Octopus AIM VCT and Octopus AIM VCT 2 (together the Octopus AIM VCTs). Investors will have exposure to a well-established portfolio of maturing and profitable ...
Launched in 1998, Elderstreet VCT is a generalist VCT that provides development and growth capital and largely invests in unquoted companies but also offers investors some exposure to AIM. This is a £20 million top up ...
Pembroke VCT originally launched in 2013, with the B shares first raising money in 2014 and subsequently in 2016. This offer seeks to increase the size of that investment portfolio by raising another £15 million with ...
This website is directed exclusively at, and intended to be used only by, persons in the UK who will be required to self-certify as Sophisticated Investors or High Net Worth Individuals before applying to invest in any of the products featured. It is not directed at any person where (by reason of nationality, residence, domicile or otherwise) the usage of the website is prohibited.
The investment products on this website are not for everyone. They are generally higher risk and require a longer investment term. You may get back less than you invest. It is therefore important that you understand the Risks and Commitments of these products.
We’ve made every effort to ensure the accuracy of the material on this website, but cannot guarantee its accuracy or currency. It reflects our understanding of current product and tax rules, which may change in future. It is for general information only and should not be regarded as constituting an offer or a solicitation to buy or sell any securities, or as investment or tax advice. If you are in any doubt as to the suitability of the products for your circumstances, please seek specialist financial or tax advice.
Wealth Club Limited is not responsible for the content of external third party material featured on our website.